Tech Company Financing Transactions
Biophta Funding Round
Elaia Partners, GO Capital and UI Investissement joined a $7 million Seed venture round for Biophta. The round was announced on 6/3/2024.
Transaction Overview
Company Name
Announced On
6/3/2024
Transaction Type
Venture Equity
Amount
$7,000,000
Round
Seed
Investors
Proceeds Purpose
The company intends to use the funds to accelerate first-in-human trial of topical ophthalmic inserts in the treatment of glaucoma and to advance a second program in macular edema, thus targeting the two leading causes of blindness.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
8, rue Maria Helena Viera Da Silva
Paris, 75014
France
Paris, 75014
France
Phone
Undisclosed
Website
Email Address
Overview
World Health Organization evaluates between 200 and 300 million, the number of people who are visually impaired by diseases against which pharmaceutical treatments are however existing. Many of these conditions have in common to cause permanent vision loss if they are not treated consistently.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jean Garrec
Chief Technical Officer
Jean Cuiné
Browse more venture capital transactions:
Prev: 6/3/2024: Seqana venture capital transaction
Next: 6/3/2024: Gireve venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on every notable VC transaction. VC transactions reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs